Experience

Davis Polk advised the joint bookrunners in connection with a Rule 144A/Regulation S offering by Imperial Tobacco Finance PLC of $4.5 billion aggregate principal amount of notes guaranteed…

Davis Polk advised Capio AB (publ) on its initial public offering and listing of shares on NASDAQ Stockholm. Assuming full exercise of the overallotment option, 52,934,872 shares were sold…

Davis Polk advised Pandox Aktiebolag (publ) on its initial public offering and listing of B Shares on NASDAQ Stockholm. Assuming full exercise of the overallotment option, 60,000,000 B…

Davis Polk advised the joint global coordinators, joint bookrunners and co-lead manager in the initial public offering of 57,518,970 shares of Nordax Group AB (publ) (“Nordax”) on Nasdaq…

Davis Polk advised Biotie Therapies Corp. (“Biotie”) on its $56.7 million U.S. initial public offering of 3,806,047 American Depositary Shares (“ADSs”) representing 304,483,760 ordinary…

Davis Polk advised the dealers of a senior unsecured Rule 144A/Regulation S offering by Crédit Agricole S.A. (“Crédit Agricole”), as issuer, acting through its London branch, of series no…

Davis Polk advised Markit Ltd. in connection with its SEC-registered secondary offering of 27,501,271 common shares sold by 15 selling shareholders, including 1,754,667 shares sold upon the…

Davis Polk advised the managers of the Rule 144A/Regulation S offering by NXP B.V. and NXP Funding LLC of $600 million principal amount of 4.125% senior notes due 2020 and $400 million…

Davis Polk advised the joint book-running managers of a $1 billion SEC-registered offering by ArcelorMittal consisting of $500 million aggregate principal amount of 5.125% notes due 2020…

Davis Polk advised the joint book-running managers on the Rule 144A/Regulation S offering by Skandinaviska Enskilda Banken AB (publ) of $1 billion aggregate principal amount of 2.45% notes…